Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors.

MLA

Ren, Hongru, et al. “Prescription Patterns of Sodium and Calcium Polystyrene Sulfonate in Patients with Hyperkalemia and Chronic Kidney Disease Receiving RAAS Inhibitors.” Clinical Kidney Journal, vol. 15, no. 9, Sept. 2022, pp. 1713–19. EBSCOhost, https://doi.org/10.1093/ckj/sfac077.

APA

Ren, H., Leon, S. J., Whitlock, R., Rigatto, C., Komenda, P., Bohm, C., Collister, D., & Tangri, N. (2022). Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors. Clinical Kidney Journal, 15(9), 1713–1719. https://doi.org/10.1093/ckj/sfac077

Chicago

Ren, Hongru, Silvia J Leon, Reid Whitlock, Claudio Rigatto, Paul Komenda, Clara Bohm, David Collister, and Navdeep Tangri. 2022. “Prescription Patterns of Sodium and Calcium Polystyrene Sulfonate in Patients with Hyperkalemia and Chronic Kidney Disease Receiving RAAS Inhibitors.” Clinical Kidney Journal 15 (9): 1713–19. doi:10.1093/ckj/sfac077.